DISEASE INDICATIONS: Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis, Polyangiitis
MANUFACTURER: Celltrion Healthcare Hungary Kft / Teva Pharmaceuticals
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Truxima (rituximab) is a drug employed in the management of various medical conditions, including follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL), chronic lymphocytic leukemia (CLL), severe active rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.
